Abiraterone acetate crystal form and preparation method thereof

A technology of abiraterone acetate and crystal form, applied to a new crystal form of the prostate cancer treatment drug abiraterone acetate and its preparation, the pharmaceutical composition of the new crystal form, the application field in the treatment of prostate cancer, can solve the problem of Unable to inhibit androgen and other problems, to achieve good stability and activity, good preparation adaptability, suitable for long-term storage effect

Inactive Publication Date: 2012-01-18
CHONGQING PHARMA RES INST
View PDF4 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Androgens can promote the growth of prostate cancer cells. At present, castration therapy, including drugs and surgery, is generally the first choice for patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Abiraterone acetate crystal form and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Preparation of Abiraterone Acetate Form E

[0070] In a 100ml reaction bottle, add 10g of abiraterone acetate and 50ml of acetonitrile, heat up to reflux to dissolve completely, cool to below 10°C to crystallize at a stirring speed of 140~150 rpm, filter, and depressurize the obtained solid Dry to obtain the crystal form E of abiraterone acetate. The measured X-ray powder diffraction pattern is shown in figure 1 , the measured values ​​are as follows (take peaks whose relative intensity is greater than or equal to 7%),

[0071] d value 2θ value Relative Strength(%) 15.12 5.8° 31 9.28 9.5° 7 7.31 12.1° 48 7.01 12.6° 7 5.95 14.9° 66 5.84 15.2° 62 5.54 16.0° 50 5.13 17.3° 17 4.81 18.4° 100 4.66 19.0° 65 4.48 19.8° 21 4.07 21.8° 46 3.95 22.5° 30 3.85 23.1° 40 3.78 23.5° 10 3.65 24.4° 10 3.50 25.5° 14 3.42 26.0° 7 3.31 26.9° 8 3.23 27.6° 23 ...

Embodiment 2

[0073] Preparation of Abiraterone Acetate Form E

[0074] In a 500ml reaction bottle, add 5g of abiraterone acetate and 80ml of methanol, dissolve the product completely at 30~35°C, add 160ml of water at a stirring speed of 50~60 rpm, crystallize, filter, and obtain a solid Dry under reduced pressure to obtain the crystal form E of abiraterone acetate.

[0075]

Embodiment 3

[0077] Preparation of Abiraterone Acetate Form E

[0078] In a 100ml reaction bottle, add 10g of abiraterone acetate and 50ml of ethanol, heat up to reflux to dissolve the product completely, cool to below 0°C to crystallize at a stirring speed of 190~250 rpm, and filter to obtain abiraterone acetate Dragonglass Form E.

[0079]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a new crystal form of a medicament, namely abiraterone acetate for treating prostatic cancer and a preparation method thereof, a pharmaceutical composition containing the new crystal form, and application of the new crystal form in preparing medicines for treating prostatic cancer.

Description

[0001] technical field [0002] The present invention relates to the fields of organic chemistry and pharmacy, in particular to a new crystal form of abiraterone acetate, a drug for treating prostate cancer, and a preparation method thereof, as well as a pharmaceutical composition of the new crystal form and its application in the treatment of prostate cancer . Background technique [0003] Abiraterone acetate, chemical name: (3β)-17-(3-pyridyl)-androst-5,16-dien-3-ol acetate, the structure is shown in formula I, [0004] . [0005] [0006] Abiraterone acetate can be converted into abiraterone in the body. Abiraterone is a cytochrome oxidase P450 (CYP450)c17 inhibitor, which reduces androgen levels by inhibiting the key enzyme in androgen synthesis-CYP450c17, so , Abiraterone not only inhibits the androgen produced by the testes but also other parts of the body such as the adrenal gland. [0007] Androgens can promote the growth of prostate cancer cells. At present, c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07J43/00A61K31/58A61P35/00
Inventor 刑乃果石瑞那郑德平邓杰罗杰叶文润
Owner CHONGQING PHARMA RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap